Suppl Information from Dual mTOR Kinase Inhibitor MLN0128 Sensitizes HR<sup>+</sup>/HER2<sup>+</sup> Breast Cancer Patient-Derived Xenografts to Trastuzumab or Fulvestrant
Pei-Yin Hsu, Shiuan Chen(City of Hope)
Cited by 0
Related Papers
Blueberry Phytochemicals Inhibit Growth and Metastatic Potential of MDA-MB-231 Breast Cancer Cells through Modulation of the Phosphatidylinositol 3-Kinase Pathway
|Cancer Research|2010|217
Environmental exposures during windows of susceptibility for breast cancer: a framework for prevention research
|Breast Cancer Research|2019|206
Treatment for the endocrine resistant breast cancer: Current options and future perspectives
|The Journal of Steroid Biochemistry and Molecular Biology|2017|46
Modulation of in Situ Estrogen Synthesis by Proline-, Glutamic Acid-, and Leucine-Rich Protein-1: Potential Estrogen Receptor Autocrine Signaling Loop in Breast Cancer Cells
|Molecular Endocrinology|2007|39
Heat Shock Protein 90 Inhibitors: New Mode of Therapy to Overcome Endocrine Resistance
|Cancer Research|2009|34